These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 16875716)

  • 21. Individual and partner risk factors associated with abnormal cervical cytology among women in HIV-discordant relationships.
    Soh J; Rositch AF; Koutsky L; Guthrie BL; Choi RY; Bosire RK; Gatuguta A; Smith JS; Kiarie J; Lohman-Payne B; Farquhar C
    Int J STD AIDS; 2014 Apr; 25(5):315-24. PubMed ID: 24047885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Usefulness of Hybrid Capture II detection of high-risk human papillomavirus in women with abnormal pap-smears of the uterine cervix].
    Tena D; Garrido N; Menéndez JM; Delgado JJ; Romanyk J; González Mdel R; Zapico A; Beltrán M
    Enferm Infecc Microbiol Clin; 2005 Oct; 23(8):474-8. PubMed ID: 16185561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection.
    Temmerman M; Tyndall MW; Kidula N; Claeys P; Muchiri L; Quint W
    Int J Gynaecol Obstet; 1999 May; 65(2):171-81. PubMed ID: 10405062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colpocytological abnormalities in HIV infected and uninfected pregnant women: prevalence, persistence and progression.
    Carriero C; Fascilla FD; Cramarossa P; Lepera A; Bettocchi S; Vimercati A
    J Obstet Gynaecol; 2018 May; 38(4):526-531. PubMed ID: 29390909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
    JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible?
    Atashili J; Adimora AA; Ndumbe PM; Ikomey GM; Rinas AC; Myers E; Eron J; Smith JS; Miller WC
    Cancer Epidemiol; 2012 Jun; 36(3):263-9. PubMed ID: 22047636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-vaccination epidemiology of human papillomavirus infections in Japanese women with abnormal cytology.
    Yamasaki K; Miura K; Shimada T; Ikemoto R; Miura S; Murakami M; Sameshima T; Fujishita A; Kotera K; Kinoshita A; Yoshiura K; Masuzaki H
    J Obstet Gynaecol Res; 2011 Nov; 37(11):1666-70. PubMed ID: 21793993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPV-based cervical cancer screening in a population at high risk for HIV infection.
    Womack SD; Chirenje ZM; Gaffikin L; Blumenthal PD; McGrath JA; Chipato T; Ngwalle S; Munjoma M; Shah KV
    Int J Cancer; 2000 Jan; 85(2):206-10. PubMed ID: 10629079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study.
    Bateman AC; Katundu K; Mwanahamuntu MH; Kapambwe S; Sahasrabuddhe VV; Hicks ML; Chi BH; Stringer JS; Parham GP; Chibwesha CJ
    BMC Cancer; 2015 Jul; 15():541. PubMed ID: 26205980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1-induced immunosuppression. DIANAIDS Collaborative Study Group.
    Rezza G; Giuliani M; Branca M; Benedetto A; Migliore G; Garbuglia AR; D'Ubaldo C; Pezzotti P; Cappiello G; Pomponi Formiconi D; Suligoi B; Schiesari A; Ippolito G; Giacomini G
    Eur J Epidemiol; 1997 Dec; 13(8):937-43. PubMed ID: 9476825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India.
    Sahasrabuddhe VV; Bhosale RA; Kavatkar AN; Nagwanshi CA; Joshi SN; Jenkins CA; Shepherd BE; Kelkar RS; Sahay S; Risbud AR; Vermund SH; Mehendale SM
    Int J Cancer; 2012 Jan; 130(1):234-40. PubMed ID: 21387289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia.
    Shipitsyna E; Zolotoverkhaya E; Kuevda D; Nasonova V; Romanyuk T; Khachaturyan A; Orlova O; Abashova E; Kostyuchek I; Shipulina O; Anttila A; Savicheva A
    Cancer Epidemiol; 2011 Apr; 35(2):160-4. PubMed ID: 20884314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.
    Sellors JW; Lorincz AT; Mahony JB; Mielzynska I; Lytwyn A; Roth P; Howard M; Chong S; Daya D; Chapman W; Chernesky M
    CMAJ; 2000 Sep; 163(5):513-8. PubMed ID: 11006761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy.
    Heard I; Schmitz V; Costagliola D; Orth G; Kazatchkine MD
    AIDS; 1998 Aug; 12(12):1459-64. PubMed ID: 9727566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A comparison of human papillomavirus detection and ThinPrep cytology test for women in Guangdong province].
    Xue YH; Chen ZX; Zheng BW; Zhang JM; Zhu QY
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):283-5. PubMed ID: 15996320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.
    Arora R; Kumar A; Prusty BK; Kailash U; Batra S; Das BC
    Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):104-9. PubMed ID: 15950365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.
    Kelly H; Weiss HA; Benavente Y; de Sanjose S; Mayaud P;
    Lancet HIV; 2018 Jan; 5(1):e45-e58. PubMed ID: 29107561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART.
    Madeddu G; Mameli G; Capobianco G; Babudieri S; Maida I; Bagella P; Rocca G; Cherchi PL; Sechi LA; Zanetti S; Nunnari G; Dessole S; Mura MS
    Eur Rev Med Pharmacol Sci; 2014; 18(8):1277-85. PubMed ID: 24817305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women.
    Minkoff H; Zhong Y; Strickler HD; Watts DH; Palefsky JM; Levine AM; D'Souza G; Howard AA; Plankey M; Massad LS; Burk R
    Infect Dis Obstet Gynecol; 2008; 2008():587082. PubMed ID: 18437233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.